Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FWXSQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,709
Award facts
- Contract value 100% obligated
- $14,708.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,708.63 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml units. This non-set-aside, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company holds significant standing within the DLA Medical Supply Chain through competitive awards across its extensive pharmaceutical portfolio. This specific delivery order for Cosentyx, a biologic immunosuppressant typically used for autoimmune conditions, demonstrates AmerisourceBergen's role in fulfilling specialized pharmaceutical requirements for federal healthcare programs. The firm fixed-price structure and rapid completion timeline reflect the urgent nature of this medical supply procurement within the broader pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DB25FWXSQ?
SPE2DB25FWXSQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FWXSQ worth?
The government has obligated $14,709 on SPE2DB25FWXSQ.
Is contract SPE2DB25FWXSQ an order under another contract?
Yes. SPE2DB25FWXSQ is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWXSQ competed?
The extent of competition for SPE2DB25FWXSQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award